IDO1 and head and neck squamous cell carcinoma: Furthermore, inhibition of IDO by 1-methyl-tryptophan (1-MT, IDO inhibitor) or dinaciclib, which is recognized as an indirect inhibitor of this enzyme, showed a synergistic effect when co-administered with temozolomide in head and neck squamous cell carcinomas [73,74].